mesothelioma

Mesothelioma patients may have received more than ever, a new drug for the treatment and prevention of this deadly cancer purposes. From China and the U.S. Drug researchers are co-receptors KDR / pack inhibitors, which would end the growth of cancer cells in patients.

The two companies, the pioneer of China Pharmaceutical Group and OSI Pharmaceuticals in the United States, is based on Chinese projects. OSI, specializing in the discovery and innovative molecular targeted therapy development. The drug known as OSI, now 930, has been shown to small and treatment of non-small cell lung cancer, colon cancer, stomach cancer and other cancers of the positive results. It is in the treatment of these cancers the effectiveness of the team, as well as on its mesothelioma treatment.

Mesothelioma, a rare form of lung cancer is determined by asbestos. Weight, until 1980 for the construction, shipbuilding, metal plates and other industrial undertakings, since asbestos has been found to be a dangerous mineral material, and has caused thousands of deaths. The material is used to make heat-resistant and flame retardant materials, and more durable. When these substances began to break down the asbestos fibers are released into the air, where they can easily breathe in.

Once inside the human body, asbestos fibers were dependent on mesothelium, a membrane lining the lungs, heart and abdominal organs. This fiber can not be expelled, and they remain in the body and accumulate over time. Asbestos fibers interfere with cell development and operations, leading to mesothelioma, exposure for decades.

If you find drug treatment or prevention of mesothelioma, it can provide new prospects for the nearly 3,000 new patients each year from the deadly disease of cancer pain.